SARNA- pramoxine hydrochloride lotion 
Crown Laboratories

----------

Sarna Sensitive

Active ingredient

Pramoxine Hydrochloride 1%

Purpose

External analgesic

Uses

Warnings

For external use only.

Do not use

  • in the eyes
  • over large areas of the body
  • for prolonged periods

When using this product

  • avoid contact with eyes
  • if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor.

Stop use and ask a doctor if

  • redness, irritation, swelling, or pain persists or increases.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

Aloe Barbadensis Leaf Juice, Benzyl Alcohol, Beta-Glucan, C12-18 Alkanoyl Glycerin/Sebacic Acid Copolymer, Caprylyl Glycol, Carbomer, Cetyl Alcohol, Citric Acid, Dimethicone, Ethylhexylglycerin, Glyceryl Stearate, Isopropyl Myristate, Palmitic Acid, PEG-100 Stearate, PEG-8 Stearate, Pentylene Glycol, Saccharide Isomerate, Simmondsia Chinensis (Jojoba) Seed Oil, Sodium Citrate, Sodium Hydroxide, Squalane, Stearic Acid, Tocopherol, Water

Sarna Sensitive Principal Display Panel

#1 DERMATOLOGIST RECOMMENDED TOPICAL ANTI-ITCH BRAND

Sarna

Pramoxine Hydrochloride 1%

External Analgesic Lotion

Steroid Free

SENSITIVE

ANTI-ITCH LOTION

NET WT. 7.5fl oz (222 ml)

Sarna Sensitive

SARNA 
pramoxine hydrochloride lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0316-0230
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PRAMOXINE HYDROCHLORIDE (UNII: 88AYB867L5) (PRAMOXINE - UNII:068X84E056) PRAMOXINE HYDROCHLORIDE10 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
PENTYLENE GLYCOL (UNII: 50C1307PZG)  
SACCHARIDE ISOMERATE (UNII: W8K377W98I)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
ALOE VERA LEAF (UNII: ZY81Z83H0X)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
SIMMONDSIA CHINENSIS SEED (UNII: D24K2Q1F6H)  
TOCOPHEROL (UNII: R0ZB2556P8)  
WATER (UNII: 059QF0KO0R)  
PEG-100 STEARATE (UNII: YD01N1999R)  
PEG-8 STEARATE (UNII: 2P9L47VI5E)  
SQUALANE (UNII: GW89575KF9)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
PALMITIC ACID (UNII: 2V16EO95H1)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
CARBOMER HOMOPOLYMER TYPE C (UNII: 4Q93RCW27E)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
YEAST .BETA.-D-GLUCAN (UNII: 44FQ49X6UN)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0316-0230-57222 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product01/01/2024
2NDC:0316-0230-12355 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product01/01/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01701/01/2024
Labeler - Crown Laboratories (079035945)
Establishment
NameAddressID/FEIBusiness Operations
Crown Laboratories, Inc.079035945manufacture(0316-0230)
Establishment
NameAddressID/FEIBusiness Operations
VOYANT BEAUTY, INC.243547333manufacture(0316-0230)

Revised: 5/2024
Document Id: 19b0d535-cfae-6081-e063-6294a90aba03
Set id: 19b0ce1b-e147-01a1-e063-6394a90af808
Version: 1
Effective Time: 20240530
 
Crown Laboratories